189 related articles for article (PubMed ID: 29679292)
21. PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2.
Varshosaz J; Raghami F; Rostami M; Jahanian A
J Liposome Res; 2019 Dec; 29(4):383-398. PubMed ID: 30668221
[TBL] [Abstract][Full Text] [Related]
22. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
[TBL] [Abstract][Full Text] [Related]
23. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules.
Lollo G; Ullio-Gamboa G; Fuentes E; Matha K; Lautram N; Benoit JP
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():859-867. PubMed ID: 30033321
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
Roger E; Lagarce F; Benoit JP
Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
[TBL] [Abstract][Full Text] [Related]
26. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
Chiang CS; Tseng YH; Liao BJ; Chen SY
Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
[TBL] [Abstract][Full Text] [Related]
27. Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.
Yan HM; Song J; Zhang ZH; Jia XB
Drug Deliv; 2016 Oct; 23(8):2911-2918. PubMed ID: 26644047
[TBL] [Abstract][Full Text] [Related]
28. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
[TBL] [Abstract][Full Text] [Related]
29. Biological response and cytotoxicity induced by lipid nanocapsules.
Szwed M; Torgersen ML; Kumari RV; Yadava SK; Pust S; Iversen TG; Skotland T; Giri J; Sandvig K
J Nanobiotechnology; 2020 Jan; 18(1):5. PubMed ID: 31907052
[TBL] [Abstract][Full Text] [Related]
30. Intracellular availability of poorly soluble drugs from lipid nanocapsules.
Bohley M; Haunberger A; Goepferich AM
Eur J Pharm Biopharm; 2019 Jun; 139():23-32. PubMed ID: 30851353
[TBL] [Abstract][Full Text] [Related]
31. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
[TBL] [Abstract][Full Text] [Related]
32. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
[TBL] [Abstract][Full Text] [Related]
33. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.
Saliou B; Thomas O; Lautram N; Clavreul A; Hureaux J; Urban T; Benoit JP; Lagarce F
Eur J Pharm Sci; 2013 Oct; 50(2):172-80. PubMed ID: 23831519
[TBL] [Abstract][Full Text] [Related]
34. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
[TBL] [Abstract][Full Text] [Related]
35. Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line.
Molaahmadi MR; Varshosaz J; Taymouri S; Akbari V
Iran J Pharm Res; 2019; 18(4):1676-1693. PubMed ID: 32184838
[TBL] [Abstract][Full Text] [Related]
36. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.
Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C
J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182
[TBL] [Abstract][Full Text] [Related]
37. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
[TBL] [Abstract][Full Text] [Related]
38. Improvement of the oral bioavailability of coenzyme Q10 with lecithin nanocapsules.
Zhou H; Zhang J; Long Y; Liu G; Duan M; Xia Q
J Nanosci Nanotechnol; 2013 Jan; 13(1):706-10. PubMed ID: 23646802
[TBL] [Abstract][Full Text] [Related]
39. Enhanced photostability, radical scavenging and antitumor activity of indole-3-carbinol-loaded rose hip oil nanocapsules.
Gehrcke M; Giuliani LM; Ferreira LM; Barbieri AV; Sari MHM; da Silveira EF; Azambuja JH; Nogueira CW; Braganhol E; Cruz L
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():279-286. PubMed ID: 28254296
[TBL] [Abstract][Full Text] [Related]
40. The adaptation of lipid nanocapsule formulations for blood administration in animals.
Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
